Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2014

Jan 13, 2014

30071_dirs_2014-01-13_46bec220-ac7d-4be6-99c1-df492057b2e6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2014-01-09

Reporting Person: FARRELL PETER C (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-01-09 ResMed Common Stock M 25000 $21.025 Disposed 514876 Direct
2014-01-09 ResMed Common Stock S 25000 $48.00 Disposed 489876 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-01-09 ResMed Common Stock Options $21.025 M 25000 Disposed 2014-11-07 ResMed Common Stock (25000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
ResMed Common Stock 200000 Indirect

Footnotes

F1: This transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.

F2: Represents date options first became exercisable. Options vest 1/4 per year.